Unbiased Analysis of Today's Healthcare Issues

Archive for the 'My Papers' Category

Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis

This is the title of my latest article in JMCP co-authored with Arijit Ganguli,  Yuri Sanchez Gonzalez, Jin Joo Shim, and Seth A. Seabury.  The paper’s abstract is below. BACKGROUND: There is considerable push to improve value in health care by simultaneously increasing quality while lowering or containing costs. However, for diseases that are best […]

Read the rest of this entry »

Precision medicine will increase drug prices and that’s a good thing

Check out my latest article at MedCity News looking at how the advent of precision medicine will affect patients, regulators and payers. The article describes how precision medicine will be good for patients.  Precision medicines will likely be more expensive that regular therapies, but–because they are targeted to more specific populations–aggregate spending on pharmaceuticals could increase […]

Read the rest of this entry »

Patterns of Adherence to Atypical Antipsychotics

A study titled “Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Joanna P. MacEwan, Felicia M. Forma, Jason Shafrin, Ainslie Hatch, Darius N. Lakdawalla, Jean-Pierre Lindenmayer. The abstract is below.  Go check it out! BACKGROUND: Poor medication adherence […]

Read the rest of this entry »

The Healthcare Economist on NPR

Check out my interview on NPR with Here & Now’s Jeremy Hobson about what recent changes in health insurance premiums changes mean for the future of the Affordable Care Act.  

Read the rest of this entry »

The value of adherence information

A study titled “Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Taylor T. Schwartz, Darius N. Lakdawalla, and Felicia M. Forma.  The abstract is below.  Go check it out!   […]

Read the rest of this entry »

Evaluating Matching-Adjusted Indirect Comparisons in Practice

One of my papers on matching-adjusted indirect comparisons (MAIC) was published today, with co-authors Anshu Shrestha, Amitabh Chandra, M. Haim Erder, and Vanja Sikirica.  The title is: “Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder” and the abstract is below.  Check it out! Differences in patient characteristics across trials may bias efficacy estimates […]

Read the rest of this entry »

Value frameworks are here: What to do about them?

The Healthcare Economist has been published in this month’s edition of Pharmaceutical Commerce.  The article, titled Value frameworks are here: What to do about them?,  provides a brief overview of the existing value frameworks and describes what steps life sciences company can take to evaluate the value of their innovations.   Value frameworks are here: What to do about […]

Read the rest of this entry »

Are You Just a Number?

That is the abbreviated title of a new commentary on the Forbes blog that I wrote with Tomas Philipson.  The full article is HERE.  An excerpt is below. New value frameworks in health care have emerged due to increasing cost pressures. Although value frameworks can be useful tools, they should be used to complement the […]

Read the rest of this entry »

Healthcare Economist in JAMA

Along with co-authors Amitabh Chandra and Ravinder Dhawan, please check out my most recent publication “Utility of Cancer Value Frameworks for Patients, Payers, and Physicians” in the latest issue of JAMA.

Read the rest of this entry »

Preferences for Nonvalvular Atrial Fibrillation Therapies

Below is an abstract from on of my recent studies on patient and physician preferences for treatments for nonvalvular atrial fibrillation.  The full article is HERE. Objectives The objective of this study was to compare patient and physician preferences for different antithrombotic therapies used to treat nonvalvular atrial fibrillation (NVAF). Methods Patients diagnosed with NVAF […]

Read the rest of this entry »